Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy.
about
Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on PhysiopathologyRelationship between C-Reactive Protein Level and Diabetic Retinopathy: A Systematic Review and Meta-AnalysisC-reactive protein genetic variant is associated with diabetic retinopathy in Chinese patients with type 2 diabetesArterial stiffness is increased in patients with type 1 diabetes without cardiovascular disease: a potential role of low-grade inflammation.Oxidized Low-Density Lipoprotein and the Incidence of Proliferative Diabetic Retinopathy and Clinically Significant Macular Edema Determined From Fundus Photographs.Altered inflammation, paraoxonase-1 activity and HDL physicochemical properties in obese humans with and without Prader-Willi syndrome.C-reactive protein and diabetic retinopathy in Chinese patients with type 2 diabetes mellitusRelationship between ceruloplasmin and oxidative biomarkers including ferritin among healthy JapaneseProspective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial.Increased concentration of C-reactive protein in obese patients with type 2 diabetes is associated with obesity and presence of diabetes but not with macrovascular and microvascular complications or glycemic control.Antioxidant drug therapy approaches for neuroprotection in chronic diseases of the retina.Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review.Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals.The common variant Q192R at the paraoxonase 1 (PON1) gene and its activity are responsible for a portion of the altered antioxidant status in type 2 diabetes.Comparative modeling of PON2 and analysis of its substrate binding interactions using computational methods.Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.Ocular distribution of antioxidant enzyme paraoxonase & its alteration in cataractous lens & diabetic retina.Evidence for augmented oxidative stress in the subjects with type 1 diabetes and their siblings: a possible preventive role for antioxidants.Associations between diabetic retinopathy and plasma levels of high-sensitive C-reactive protein or von Willebrand factor in long-term type 1 diabetic patients.The electrophoretical determination of serum protein fractions in lycopene treated experimental diabetic rats.Some Anticancer Agents Act on Human Serum Paraoxonase-1 to Reduce Its Activity.The association of neutrophil to lymphocyte ratio, mean platelet volume, and platelet distribution width with diabetic retinopathy and nephropathy: a meta-analysis.Quantitative proteomics analysis of vitreous body from type 2 diabetic patients with proliferative diabetic retinopathy.
P2860
Q26744760-462F54EA-554C-4C8E-B90C-5C5550F33996Q26774344-25FE52AC-1E0A-4099-AB3D-D4F2E673AA2BQ35151396-EB18556C-DF4E-42FE-8382-02A6CC90A742Q35898231-D565D089-7051-48CF-A409-8A04F81A4067Q36082885-A132BEEA-AEBA-4E6A-A97C-3B00CB9FBB20Q36179991-9B2E118D-195A-42AD-A17A-D694B1F5B625Q36622467-97426459-1A21-406F-AE12-8385998AEEB1Q36670829-A26126FF-E1A0-489E-BA6D-242F91523EE9Q36763152-1C8E9BC7-609D-4308-9824-4F9B5DC699EAQ37622886-AAD579CF-F682-41D9-8123-0BBEA5B61DA6Q37645117-BA449DAE-0D21-417E-AF2D-258AE200CA73Q38682902-C689586A-127B-4239-BC40-CC1EC499A171Q39729695-E85E4D49-8DDF-4DEA-B4AE-8ED415C9688FQ39883075-8DFAC43D-3084-4DF1-8A23-4AB2E9EB3113Q42714247-7498A8BA-BA2B-4DF4-93E8-140A0C171F8BQ45072634-54BD297F-AEA3-41D2-9750-C5E29985277AQ47130480-F41CBB53-5186-4783-9A6F-7A70871E0B02Q47400131-52691A6E-A3FC-4E01-A65C-2FB874B97EB5Q50491933-14D55751-EA77-4EA8-B94E-F2E06BAFF042Q50956192-4169455B-C5D0-48EA-8BDD-51D0AB1AEB68Q51526210-CAA7746D-3E15-4C45-A49E-4051B715B260Q55512530-E6AD7FF5-C070-45A6-81DC-37B8C9558542Q55512926-6DBBF4BF-D2E5-481F-A1F1-4F1A747FF061
P2860
Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Antioxidant potential, paraoxo ...... ation in diabetic retinopathy.
@en
Antioxidant potential, paraoxo ...... ation in diabetic retinopathy.
@nl
type
label
Antioxidant potential, paraoxo ...... ation in diabetic retinopathy.
@en
Antioxidant potential, paraoxo ...... ation in diabetic retinopathy.
@nl
prefLabel
Antioxidant potential, paraoxo ...... ation in diabetic retinopathy.
@en
Antioxidant potential, paraoxo ...... ation in diabetic retinopathy.
@nl
P2093
P1476
Antioxidant potential, paraoxo ...... ration in diabetic retinopathy
@en
P2093
Beata Kos-Kudła
Bogdan Marek
Dariusz Kajdaniuk
Elzbieta Swietochowska
Jacek Karpe
Katarzyna Nowak
Lucyna Siemińska
Mariusz Nowak
P2888
P304
P356
10.1007/S10238-009-0084-7
P577
2009-12-11T00:00:00Z